Moderna is receiving up to $50 million to accelerate the development of an Ebola vaccine, as the virus continues to spread in the eastern Democratic Republic of Congo.
Moderna is receiving up to $50 million to accelerate the development of an Ebola vaccine, as the virus continues to spread in the eastern Democratic Republic of Congo.